Health
Mouse-adapted SARS-CoV-2 model helps advance the development of COVID-19 vaccines – News-Medical.Net
A new COVID-19 mouse model developed at the University of North Carolina at Chapel Hill captures many of the features of human disease and has helped advance a COVID-19 vaccine candidate to clinical trial.
Reviewed by Emily Henderson, B.Sc.Aug 27 2020
A new COVID-19 mouse model developed at the University of North Carolina at Chapel Hill captures many of the features of human disease and has helped advance a COVID-19 vaccine candidate to clinical trial.
Researchers, among them virologists and microbiologists at UNC-Chapel Hill’s Gillings School of Global Public Health, describe the mouse-adapted SARS-CoV-2 model in a paper fast-tracked and published Aug. 27 in Nature.
Small animal models that r…
-
Business23 hours agoWhy the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
General19 hours agoMigrants raise concerns over Australia’s English tests for visa applicants
-
Noosa News23 hours agoRock royalty is rolling into Hervey Bay
-
Noosa News22 hours agoNew FLC President has regional lens – Proctor